Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Shuman

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Head & Neck|January 29, 2020
Paired phase II trials evaluating cetuximab and radiotherapy for low risk HPV associated oropharyngeal cancer and locoregionally advanced squamous cell carcinoma of the head and neck in patients not eligible for cisplatinPaul L Swiecicki, Pin Li, Emily Bellile, et al.
Head & Neck|December 17, 2025
Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios Predict Improved Survival and Response to Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of the LarynxZachary Risch, Emily Bellile, Moneb S Bughrara, et al.
Oral Oncology|June 18, 2021
Implementation of human papillomavirus circulating tumor DNA to identify recurrence during treatment de-escalationCatherine T Haring, Collin Brummel, Chandan Bhambhani, et al.
Head & Neck|April 29, 2024
Follow-up for human papillomavirus-related oropharynx cancer concentrated on unequal symptom change (FOCUS): Prospective patient-reported outcome collectionDonna M Edwards, Laila A Gharzai, Weilin Wang, et al.
The Oncologist|April 6, 2021
Patient Burden with Current Surveillance Paradigm and Factors Associated with Interest in Altered Surveillance for Early Stage HPV-Related Oropharyngeal CancerLaila A Gharzai, Nicholas Burger, Pin Li, et al.
Clinical and Translational Radiation Oncology|January 13, 2022
Imaging response assessment for predicting outcomes after bioselection chemotherapy in larynx cancer: A secondary analysis of two prospective trialsLaila A Gharzai, Julia Pakela, Elizabeth M Jaworski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2021
Early HPV ctDNA Kinetics and Imaging Biomarkers Predict Therapeutic Response in p16+ Oropharyngeal Squamous Cell CarcinomaYue Cao, Catherine T Haring, Collin Brummel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 12, 2025
FDG-PET-based Selective De-escalation of Chemoradiation in Human Papillomavirus-related Oropharyngeal Squamous Cell Carcinoma: a Multi-center Phase II TrialMichelle Mierzwa, Benjamin Rosen, Krithika Suresh, et al.
Investigational New Drugs|May 27, 2016
A phase II trial of the BCL-2 homolog domain 3 mimetic AT-101 in combination with docetaxel for recurrent, locally advanced, or metastatic head and neck cancerPaul L Swiecicki, Emily Bellile, Assuntina G Sacco, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Head & Neck|January 29, 2020
Paired phase II trials evaluating cetuximab and radiotherapy for low risk HPV associated oropharyngeal cancer and locoregionally advanced squamous cell carcinoma of the head and neck in patients not eligible for cisplatinPaul L Swiecicki, Pin Li, Emily Bellile, et al.
Head & Neck|December 17, 2025
Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios Predict Improved Survival and Response to Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of the LarynxZachary Risch, Emily Bellile, Moneb S Bughrara, et al.
Oral Oncology|June 18, 2021
Implementation of human papillomavirus circulating tumor DNA to identify recurrence during treatment de-escalationCatherine T Haring, Collin Brummel, Chandan Bhambhani, et al.
Head & Neck|April 29, 2024
Follow-up for human papillomavirus-related oropharynx cancer concentrated on unequal symptom change (FOCUS): Prospective patient-reported outcome collectionDonna M Edwards, Laila A Gharzai, Weilin Wang, et al.
The Oncologist|April 6, 2021
Patient Burden with Current Surveillance Paradigm and Factors Associated with Interest in Altered Surveillance for Early Stage HPV-Related Oropharyngeal CancerLaila A Gharzai, Nicholas Burger, Pin Li, et al.
Clinical and Translational Radiation Oncology|January 13, 2022
Imaging response assessment for predicting outcomes after bioselection chemotherapy in larynx cancer: A secondary analysis of two prospective trialsLaila A Gharzai, Julia Pakela, Elizabeth M Jaworski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2021
Early HPV ctDNA Kinetics and Imaging Biomarkers Predict Therapeutic Response in p16+ Oropharyngeal Squamous Cell CarcinomaYue Cao, Catherine T Haring, Collin Brummel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 12, 2025
FDG-PET-based Selective De-escalation of Chemoradiation in Human Papillomavirus-related Oropharyngeal Squamous Cell Carcinoma: a Multi-center Phase II TrialMichelle Mierzwa, Benjamin Rosen, Krithika Suresh, et al.
Investigational New Drugs|May 27, 2016
A phase II trial of the BCL-2 homolog domain 3 mimetic AT-101 in combination with docetaxel for recurrent, locally advanced, or metastatic head and neck cancerPaul L Swiecicki, Emily Bellile, Assuntina G Sacco, et al.
Pageof 2